Don't underestimate John Palermo's ability to create price spikes - it's actually quite a good buy at around 1c.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025